| Dendritic cells as orchestrators of anticancer immunity and immunotherapy I Heras-Murillo, I Adán-Barrientos, M Galán, SK Wculek, D Sancho Nature Reviews Clinical Oncology 21 (4), 257-277, 2024 | 80 | 2024 |
| Diacylglycerol kinase α inhibition cooperates with PD-1-targeted therapies to restore the T cell activation program J Arranz-Nicolás, M Martin-Salgado, I Adán-Barrientos, R Liébana, ... Cancer Immunology, Immunotherapy, 1-13, 2021 | 21 | 2021 |
| The aged microenvironment impairs BCL6 and CD40L induction in CD4+ T follicular helper cell differentiation JS Fisher, I Adán‐Barrientos, NR Kumar, JN Lancaster Aging Cell 23 (6), e14140, 2024 | 2 | 2024 |
| Dendritic Cell‐Mediated Cross‐Priming by a Bispecific Neutralizing Antibody Boosts Cytotoxic T Cell Responses and Protects Mice against SARS‐CoV‐2 R Lázaro‐Gorines, P Pérez, I Heras‐Murillo, I Adán‐Barrientos, ... Advanced Science 10 (34), 2304818, 2023 | 2 | 2023 |
| El uso de un anticuerpo biespecífico neutralizante frente a SARS-CoV-2 y dirigido hacia DNGR-1 potencia la respuesta de las células T citotóxicas, mediante su acción a través … R Lázaro Gorines, P Pérez Ramírez, I Heras Murillo, I Adán Barrientos Inmunología (1987), 38-43, 2023 | | 2023 |
| Intracellular delivery of nucleic acids using a new type of cell penetrating peptides I Adán-Barrientos, I Lostalé-Seijo, I Louzao, J Montenegro FarmaJournal 4 (1), 82-82, 2019 | | 2019 |
| Nuevos péptidos penetrantes para la entrega intracelular de ácidos nucleicos I Adán Barrientos | | 2018 |
